Trials / Completed
CompletedNCT02319408
Immune Boost In Non-Small Cell Lung Cancer
A Randomized Phase II Study of Radiation Induced Immune Boost in Operable Non-small Cell Lung Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- University Hospital Heidelberg · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Insufficient migration and activation of tumour specific effector T cells seems to be the one important reason for inadequate host anti-tumour immune response. Ionizing radiation can induce a variety of immune responses. The goal of this randomized trial is to assess if a preoperative single fraction low dose radiation is able to improve anti-tumour immune response in operable early stage lung cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Preoperative radiation | Lobectomy for lung cancer following preoperative radiation |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2020-02-01
- Completion
- 2020-02-01
- First posted
- 2014-12-18
- Last updated
- 2022-05-23
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02319408. Inclusion in this directory is not an endorsement.